BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

24 related articles for article (PubMed ID: 15041327)

  • 1. Renal transplantation in cyclosporine-treated recipients at the Singapore General Hospital.
    Vathsala A; Woo KT
    Clin Transpl; 1999; ():189-97. PubMed ID: 11038637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15-year outcome data.
    Joss N; Rodger RS; McMillan MA; Junor BJ
    Transplantation; 2007 Mar; 83(5):582-7. PubMed ID: 17353778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute rejection in cadaveric renal transplantation under cyclosporine based therapy. Analysis of the risk factors and its influence on chronic dysfunction].
    Mota A
    Acta Med Port; 2004; 17(1):8-14. PubMed ID: 15636737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term kidney transplant outcomes in patients receiving oil-based or microemulsion formulations of cyclosporine.
    Medina-Pestana JO; Felipe CR; Park SI; Machado PG; Garcia R; Spinelli G; Silva LA; Santos CF; Tedesco-Silva H
    Transplant Proc; 2004 Mar; 36(2 Suppl):74S-79S. PubMed ID: 15041311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Living-donor kidney transplantation in the cyclosporine era].
    Campise M; Tarantino A; Berardinelli L; Finazzi S; Montagnino G; Rossini G; Scalamogna M; Cesana B; Ponticelli C
    G Ital Nefrol; 2002; 19(1):49-54. PubMed ID: 12165946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
    Nashan B
    Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Causes of late renal allograft loss: chronic allograft dysfunction, death, and other factors.
    Kreis HA; Ponticelli C
    Transplantation; 2001 Jun; 71(11 Suppl):SS5-9. PubMed ID: 11583489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine as a milestone in immunosuppression.
    Calne R
    Transplant Proc; 2004 Mar; 36(2 Suppl):13S-15S. PubMed ID: 15041300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with cyclosporine.
    Langone AJ; Helderman JH
    Transplant Proc; 2004 Mar; 36(2 Suppl):59S-63S. PubMed ID: 15041308
    [No Abstract]   [Full Text] [Related]  

  • 10. Composite outcomes in renal transplantation using cyclosporine.
    Keown PA
    Transplant Proc; 2004 Mar; 36(2 Suppl):35S-39S. PubMed ID: 15041304
    [No Abstract]   [Full Text] [Related]  

  • 11. Experience with cyclosporine.
    Sandrini S; Setti G; Bossini N; Zubani R; Cassamali S; Maiorca P; Maffeis R; Portolani N; Bonardelli S; Nodari F; Tardanico R; Corbetta G; Cancarini G
    Transplant Proc; 2004 Mar; 36(2 Suppl):152S-157S. PubMed ID: 15041327
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.